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The nuclear autoantigen SS-B/La, which is recognized 
by antibodies in certain autoimmune diseases, is com-
plexed with distinct cellular RNAs and the complex of 
antigen-RNA profile remains constant throughout the 
cell cycle. This antigen is prominent in the nucleolus 
during G 1/S phase of the cell cycle. Actinomycin Data 
concentration of 0.0005 JLg/ml is capable of abolishing 
the appearance of SS-B/La in the nucleolus. The amount 
of immune-precipitable SS-B/La-associated RNAs is re-
duced by 0.005 JLg/ml actinomycin D treatment. The 
mechanism for these findings is suggested to be related 
to inhibition of the synthesis of messenger RNA coding 
for SS-B/La. 
In t he past several years, information on antinuclear anti-
bodies of different specificities have been reported frequently. 
Some are disease specific [1,2] and some serve as excellent 
tools to elucidate the structures of certain macromolecules of 
the nucleus (3- 8]. 
In 1979, Lerner and Steitz reported that anti-Sm and anti-
nRNP sera precipitated specific small nuclear RNAs U1, U2, 
U4, US, and U6 (6]. It was subsequently reported that the U1 
RNA- protein complex might play a role in hnRNA splicing 
[9]. In addition, these authors reported t hat other unidentified 
cellular RNAs were precipitated by anti-SS-B/La and anti-SS-
A/Ro antibodies [7,8]. Furthermore, t hey demonstrated that 
anti-SS-B/La antibodies immunoprecipitated adenovirus-as-
sociated RNA (VA RNA) [7] and Epstein-Barr virus-associated 
RNAs (EBER I and II) [8]. Recently Rosa et al, Hendrick et 
al, and Rinke and Steitz reported that there were striking 
similarities between the VA RNA and EBER which were pre-
cipitated by anti-SS-B/La antibodies, and presented evidence 
that they are transcripts of RNA polymerase III [10- 12]. 
Anti-SS-B/La antibodies have been used to localize the 
expression of SS-B/La nuclear antigen in cells at different 
phases of the cell cycle. It was found that SS-B/La was present 
predominantly in the nucleoplasm of cells at Go phase but in 
G,/S phase the antigen was highly visualized in the nucleolus 
[3]. Rinke and Steitz have shown that anti-SS-B/La antibodies 
precipitated precursors of 58 ribosomal RNA and transfer 
RNAs [12]. These observations suggest SS-B/La antigen is 
actively related to cell cycle events and may be involved in 
functional roles in cell metabolism, such as the maturation of 
RNA polymerase III transcripts and/or the initiation of DNA 
synthesis. 
Actinomycin D is an antibiotic having the ability to suppress 
the synthesis of ribosomal RNA and the activity of RNA 
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polymerase II, but not the synthesis of ribosomal proteins [13-
16) . It has also been shown to inhibit the synthesis of rapid 
turnover molecules present in the nucleolus which are impor-
tant for the initiation of DNA synthesis [17]. It also delays the 
progress of ce lls from early G1 to S or M phases of the cell 
cycle. Actinomycin D is used in this study to see whether it 
possesses the ability to affect the expression of the nuclear 
antigen SS-B/La in different phases of the cell cycle. 
MATERIALS AND METHODS 
Sera 
Five human "monospecific" sera containing anti-SS-B/La antibodies 
were used in this study. Monospecific sera having anti-Sm, or anti-
nRNP activities were a lso used for comparison. The specificity of the 
anti-SS-B/La sera used was determined on the basis of previously 
reported criteria, including only one precipitin line in double immu-
nodiffusion analysis using rabbit thymus extract and WiL2 cell extract 
as the antigen sources and speckled nuclear immunofluorescence stain-
ing patterns on mouse kidney sections and WiL2 cell smears [3,4,18]. 
In immunodiffusion, they formed lines of immunologic identity with 
standard reference sera, establishing the nature of the precipitating 
antibody. In addition, by various immunoassays, including radio-
immunoassay, passive hemagglutination, immunodiffusion, and en-
zyme sensitivities, the sera were shown to be negative for antibodies to 
native DNA, histone, Sm, nRNP, and SS-A/Ro. They were in this 
sense considered to be "monospecific" for anti-SS-B/La. IgG was 
isolated from these sera using Bio-Rad DEAE Affi-Blue gel ion ex-
change chromatography, reconcentrated back to the original volume, 
and then used in the immunofluorescence stain ing and immunopreci-
pitation studies. In addition, 2 sera containing antinucleolar antibodies 
obtained from patients with progressive systemic sclerosis were used 
as controls to stain actinomycin D-treated cells. 
Cell Synchronization 
WiL2 cells, a B lymphoid cell line containing the Epstein-Barr virus 
genome, were used in this study. The growth and the method of 
synchronization were reported earlier [3]. Basically, WiL2 cells were 
synchronized by the method of starvation. The degree of synchrony 
and protein, RNA, and DNA syntheses were studied simultaneously 
and followed by using the same methods described earlier {3]. The 
synchronized cells were used to study SS-B/La-associated RNAs and 
the effect of actinomycin Don the synthesis of the SS-B/ La-associated 
RNAs and expression of SS-B/La antigen. 
Actinomycin D Treatment 
Actinomycin D was obtained from Sigma Company (St. Louis, 
Missouri) and was added into the cell suspension synchronized by 
starvation, at concentration varying from 0.0005- 1 J.Lg/ml. The cultures 
were kept at 37' C continuously for 9 h, then RNA and protein syntheses 
were determined by pulse labeling of cells with ["H]Urd and L[ 1'C] 
amino acids, respectively, for 30 min. The actinomycin D-treated cells 
were also cytocentrifuged onto slides and used as the substrates for 
indirect immunofluorescence using anti-SS-B/La lgG and antinucleo-
lar antibody containing human antiserum. Actinomycin D at the con -
centrations of0.005 J.Lg/ml and 0.0005 l'g/ml was used to study its effect 
on the synthesis of the nuclear antigen-associated RNAs. 
Indirect I mmunofluorescen.ce 
Synchronized WiL2 cells, either actinomycin D-treated or untreated, 
were cytocentrifuged onto slides and fixed in acetone at room temper-
ature for 10 min and used as the substrates. Anti-SS-B/ La IgG and 
sera containing ant inucleolar antibodies were reacted with the cells for 
30 min. The anti-SS-B/La IgG used was diluted to 1:80 (original 
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antibody titers 1:320) and t he antinucleolar antibody-containing sera 
used were diluted to 1:640 (original antibody titers 1:2560). After 
washing in phosphate-buffered saline, fluorescein isothiocyanate-la-
beled goat antihuman lgG was added and incubated for another 30 
min. Thereafter, the slides were washed again and mounted with 
buffered glycerine and observed under a fluorescent microscope [3). 
In Vitro Labeling and Preparation of Cell Extract 
Cells from different phases of the cell cycle were labeled with (32P) 
phosphoric acid in the following manner: 1, 6, 11, 16, and 21 h after 
release from starvation synchronization, the cells were centrifuged and 
then resuspended into phosphate-free medium containing 10% fetal 
calf serum, 2 mM glutamine, and 1 mCi [32P )phosphoric acid/20 X 106 
cells and incubated at 37"C for 4 h. Thereafter, the cells were harvested 
and washed in cold phosphate-buffered saline (PBS), pH 7.0 at least 
twice, and finally t he cells were resuspended into PBS at a final 
concentration of 2 x 107/ml. The cells were disrupted by extensive 
sonication at 4 ·c and the supernatant, after clarification by centrifu-
gation at 12,000 g for 20 min, collected as a source of antigen for 
studying immune-precipitable RNAs. 
Immune Precipitation. 
Two hundred microliters of cell extract were reacted with 10 Ill of 
lgG and incubated for 15 min. Fifty microliters of protein A bearing 
staphylococci (Staph A) (Calbiochem Co., La Jolla, California) (Pan -
sorbin) was added, and the mixture was incubated for another 15 min. 
The Staph A suspension was collected by centrifugation at 10,000 g for 
1 min and washed extensively in PBS containing 0.5% NP-40, 0.5% 
deoxycholate, 0.1 % sodium dodecyl sulfate, (SDS) and 1 mM Na2EDTA. 
The immune complexes were subsequently eluted from the Staph A at 
60"C for 15 min in 50 Ill of 50 mM Tris, pH 8.0, 3% SDS, and 10% 
glycerol. To prepare RNA, the immune complexes were treated with 
100 llg/ml of proteinase K (Boehringer Mannheim) for 30 min at 37"C, 
mixed with 50 Ill of formamide, and boiled for 2 min. Bromophenol 
Blue was added and the samples were subjected to electrophoresis on 
24 em, 10% acrylam ide (24:1, acrylamide:bis-acrylamide), 7 M urea, 89 
mM Tris-borate-EDTA, pH 8.2 (89 mM Tris, 89 mM boric acid, 2.5 mM 
EDTA) at 200 V for 15 h. Radioactive RNA was detected by autora-
diography using Kodak XRP-5 film. 
RESULTS 
WiL2 cells were synchronized by the method of starvation, 
as reported earlier [3]. RNA and DNA syntheses were deter-
mined and the radioisotope uptakes are shown in Fig 1. DNA 
synthesis started to increase 8- 10 h after the cells were released 
from starvation . The time period- immediately after the re-
lease from starvation to the beginning of DNA synthesis- was 
the G1 phase of the cell cycle. RNA and protein were synthe-
sized earlie r than DNA, starting about 2-4 h after release from 
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FIG 1. WiL2 cells synchronized by the method of starvation . (3H) 
dThd uptake (e - -- - e), ['1H]Urd uptake (0 ---- 0), and L[ 1'C] 
amino ac id uptake (6 --- - 6) were determined. In the first 8- 10 h, 
little DNA was synthesized and this period corresponded to the G1 
phase of the cell cycle. RNA and protein were synthesized continuously 
from 2 h after release from starvation and reached their peak at 10 h 
and 14- 16 h, respectively. The degree of synchrony was determined by 
percentage of cells showing DNA synthesis after autoradiography (not 
shown here). 
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FIG 2. Dose effect of actinomycin Don protein and RNA syntheses. 
Cells synchronized by the method of starvation were treated with 
various concentrations of actinomycin D for 9 h and then pulse labeled 
with (3H]Urd (e ---- e) or ["C]amino acids, (0 --- 0) for 30 min 
and syntheses were measured by the isotope uptake. 
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FIG 3. Gel electrophoresis profiles of immune-precipitable RNAs 
from WiL2 cells at various phases of cell cycle. Lanes A were the SS-
B/La-associated RNA profiles, lanes B for Sm-associated RNA profiles, 
lanes C for nRNP-associated profiles. The RNA species associated with 
the individual nuclear antigens remained the same throughout the cell 
cycle and in all cases the synthesis of the RNAs was greater in late G, 
and S phases. 
starvation, and continued throughout the cell cycle with peaks 
at 10 hand 10- 16 h, respect ively. 
The effect of actinomycin D on the synthesis of protein and 
RNA is shown in Fig 2. Actinomycin D at the concentration of 
0.005 J.Lg/ml inhibited about 50% synthesis of protein and 
RNAs. 
The association between the nuclear antigens and the small 
nuclear RNAs at various phases of the cell cycle was studied 
using "2P- labeled synchronized WiL2 cells. Fig 3 represents the 
precipitated RNA profiles from cells at G1 (1- 5 h), late G1 (6-
10 h), S (16-20 h), and late S to G2/M (21-25 h) phases of cell 
cycle. Anti-SS-B/La antibodies immunoprecipitated at least 6 
different RNAs (lanes A). The top two bands corresponded to 
the EBER I and II as described by Lerner eta! [8]. The third 
band corresponded to the 58 RNA and there was a broad band 
of 4.5 S RNA which comigrated with two other unidentified 
small RNAs. Anti -Sm antibodies (lanes B) immunoprecipitated 
2 major RNAs which corresponded to U2 and U1 RNAs and 3 
minor RNAs (U4, U5, and U6). Anti-nRNP antibodies were 
associated with U1 RNA only (lanes C) . The precipitation of 
U1 RNA by anti-nRNP and anti-Sm could be related to the 
partial identity of nRNP antigen to Sm antigen shown in the 
double immunodiffusion analysis [2], or the contamination of 
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anti-nRNP in the anti-Sm serum which could not be detected 
by the conventional available methods. The small RNA profiles 
at different phases of the cell cycle looked similar. The rate of 
these RNA syntheses increased as the cells proceeded from Go 
to early G, and S phases and then appeared to remain constant 
at subsequent phases of the cell cycles. 
Actinomycin D was used to study its effect on the nuclear 
antigen-associated RNAs. The synchronized WiL2 cells at G0 
phase were treated with actinomycin D at the concentrations 
of 0.005 ~Lg/ml and 0.0005 11g/ml and labeled with ["2P )phos-
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FIG 4. Gel electrophoresis profiles of immune-precipitable RNAs 
from WiL2 cells by SS-B/La antibodies. Lane I was from cells at late 
G, phase and lane 2 from cells treated with actinomycin D 0.005 11g/ 
mi. Actinomycin D suppressed the synthesis of SS-B/La-associated 
RNAs. 
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phoric acids for 4 h. The 32P-labeled, actinomycin D-treated 
WiL2 cell extracts were then used for the immunoprecipitation 
with anti-SS-B/La IgG. The radioactivity of the immune com-
plexes from actinomycin D 0.005 11g/ml-treated cells was less 
than those from the untreated controls (serum 1: 47 X 10~ cpm 
vs 185 X 103 cpm; and serum 2: 156 X 103 cpm vs 373 x 103 
cpm). However, there was no significant difference between the 
controls and the 0.0005 ~Lg/ml actinomycin D-treated groups 
(serum 1: 142 x 103 cpm; and serum 2: 332 x 103 cpm). The 
SS-B/La-associated RNAs from the actinomycin D-treated 
cells were analyzed and the RNA profile thus obtained was 
similar to that from the control as shown in Fig 4. However, 
the amount of RNAs was reduced substantially, especially when 
actinomycin D at the concentration of 0.005 J.l.g/ml was used 
(Fig 4, lane 2) . The amount of SS-B/La-associated RNAs from 
0.0005 ~Lgfml actinomycin D-treated cells seemed not to be 
affected (data not shown). Anti-Sm and anti-nRNP antibodies 
were also used to immunoprecipitate actinomycin D-treated or 
untreated 32P- labeled WiL2 cell extracts. The radioactivity and 
the RNA profiles thus obtained were similar and there was no 
significant difference (data not shown). 
Fig 5 depicts the effect of actinomycin D on the expression 
of SS-B/La antigen under the fluorescent microscope. Ia and 
Ila were the control staining patterns using antinucleolar an-
tibodies and anti-SS-B/La antibodies, respectively. Antinucleo-
lar antibodies showed the expected nucleolar staining and the 
anti-SS-B/La antibodies gave nucleoplasmic speckled staining 
and also nucleolar staining from cells collected at late G1 phase 
of the cell cycle (9-10 h after release from starvation) (Fig 5, 
upper panel) . However, when actinomycin D was added at the 
concentration of 0.0005 ~Lg/ml, the expression of SS-B/La on 
the nucleolus was abolished (Jib), while the nucleolar staining 
by antinucleolar antibodies still remained obvious (Ib), but 
appeared smaller (Fig 5, lower panel). Higher concentration of 
actinomycin D induced fragmentation of nucleoli and disorgan-
ization of cell nuclei. The staining patterns with the antinu-
cleolar antibodies and anti-SS-B/La antibodies thus obtained 
became clumpy, especially when the cells were treated with 
FIG 5. Fluorescent microphotogra-
phy of the stainings by nucleolar anti-
bodies(/), and SS-B/La antibodies (II). 
The cells were synchronized at G0 phase 
by the starvation method (3] and then 
released to proceed to late G, phase. 
Aliquots of cells were t reated with acti-
nomycin D. The cells were harvested 9 
h late r and prepared for indirect immu-
nofluorescence using SS-B/La antibod-
ies and nucleolar antibodies. a-Control, 
untreated; b-actinomycin D 0 .0005 p.g/ 
ml treated. X 2400. 
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actinomycin D at the concentration of 0.05 !Lg/ml or higher 
(data not shown). 
DISCUSSION 
88-B/La nuclear antigen is a very dynamic cellula r compo-
nent and its distribution is cell -cycle related [3]. It is present 
in the nucleoplasm of cells at resting and early G, phases and, 
in addition, a lso present in the nucleolus of cells at late G, to 
early 8 phases [3]. The migration of SS-B/La from one place 
to another p lace indicates that 88-B/La antigen might have 
some important biologic functions related to the t ransport of 
some cellu lar components such as ribosomal RNAs which are 
present in cytoplasm, nucleoplasm, and nucleolus. This notion 
is confirmed by the observation of Rinke and Steitz [12]. They 
demonstrated that 88-B/La antigen recognized precursor 
forms of 58 RNA and certain transfer RNA [12], and some 
newly synthesized 58 RNA molecules were transiently associ-
ated with 88-B/La antigen [12]. The migration of SS-B/La 
from nucleoplasm to nucleolus is sensitive to actinomycin D 
treatment at a concentration of 0.0005 !Lg/ml which is much 
lower than that needed to suppress ribosomal RNA synthesis 
[14,15] . The amount of 88-B/La associated RNAs was a lso 
reduced by actinomycin D (see Fig 4). Considering t hese two 
facts, it seems that actinomycin D could have the capability to 
suppress either the synthesis of 88-B/La protein or the SS-B/ 
La-associated RNAs. 58 and 4.58 RNAs are 88-B/La-associ-
ated RNAs (s.ee Fig 3, lanes A, and Fig 4) [7,8,10-12]; they are 
transcript product of RNA polymerase III [8,10- 12] and their 
synthesis is resistant to actinomycin D [19]. Actinomycin D 
has been shown to have an inhibitory effect on RNA polymerase 
II activity, but not on RNA polymerase III activity [13,16]. So, 
the reduced amounts of 58 and 4.58 RNAs precipitated by anti-
88-B/La antibodies are probably due to insufficient SS-B/La 
protein whose synthesis is suppressed by actinomycin D. The 
mechanism for such inhibition is not clear at present. Probably 
it is due to inhibition of messenger RNA coding for SS-B/La 
protein, or simply due to the toxic effect of actinomycin D. It 
has been suggested t hat actinomycin D inh ibits rRNA synthesis 
through the inhibition of the synthesis of messenger RNA of 
high turnover which codes for the proteins required for nucleo-
lar activity [13,16]. SS-B/La has been found to be a cellular 
component of high turnover (L. I. Pizer, personal communica-
tion). So it is probable t hat SS-B/La protein is one of these 
cellular components. If this is the case, it can explain the fact 
that SS-B/La protein can be present in the nucleoplasm and 
also in nucleolus during certain stages of the cell cycle. In 
summary, actinomycin D has a selective effect on t he expres-
sion of nuclear antigen 88-B/La. This might be useful in the 
future to probe the functional ro le of this nuclear/nucleolar 
protein . 
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